Yumi Noda

Dr. Yumi Noda

Department of Nephrology, Nitobe Memorial Nakano General Hospital, Tokyo 164-8607, Japan
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
YNYumi Noda
Yumi Noda
SSSei Sasaki
Sei Sasaki

4 August 2008 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
YNYumi Noda
Yumi Noda
SHSaburo Horikawa
Saburo Horikawa
EKEiichiro Kanda
Eiichiro Kanda
MYMaho Yamashita
Maho Yamashita
HMHu Meng
Hu Meng
SSSei Sasaki
Sei Sasaki
Trafficking of water channel aquaporin-2 (AQP2) to the apical membrane and its vasopressin and protein kinase A (PKA)–dependent regulation in renal collecting ducts is critical for body water homeostasis. We previously identified an AQP2 binding protein complex including actin and tropomyosin-5b (TM5b). We show that dynamic interactions between AQP2 and the actin cytoskeleton are critical for initiating AQP2 apical targeting. Specific binding of AQP2 to G-actin in reconstituted liposomes is negatively regulated by PKA phosphorylation. Dual color fluorescence cross-correlation spectroscopy reveals local AQP2 interaction with G-actin in live epithelial cells at single-molecule resolution. Cyclic adenosine monophosphate signaling and AQP2 phosphorylation release AQP2 from G-actin. In turn, AQP2 phosphorylation increases its affinity to TM5b, resulting in reduction of TM5b bound to F-actin, subsequently inducing F-actin destabilization. RNA interference–mediated knockdown and overexpression of TM5b confirm its inhibitory role in apical trafficking of AQP2. These findings indicate a novel mechanism of channel protein trafficking, in which the channel protein itself critically regulates local actin reorganization to initiate its movement.

25 May 2004 in FEBS Letters
Verified
Journal Article
Closed access
YNYumi Noda
Yumi Noda
SHSaburo Horikawa
Saburo Horikawa
TFTetsushi Furukawa
Tetsushi Furukawa
KHKeiji Hirai
Keiji Hirai
YKYoshifumi Katayama
Yoshifumi Katayama
SSSei Sasaki
Sei Sasaki

1 May 2005 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YNYumi Noda
Yumi Noda
SHSaburo Horikawa
Saburo Horikawa
YKYoshifumi Katayama
Yoshifumi Katayama
SSSei Sasaki
Sei Sasaki

1 December 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KEKayoko Eto
Kayoko Eto
YNYumi Noda
Yumi Noda
SHSaburo Horikawa
Saburo Horikawa
SUShinichi Uchida
Shinichi Uchida
SSSei Sasaki
Sei Sasaki
Vasopressin-regulated water reabsorption through the water channel aquaporin-2 (AQP2) in renal collecting ducts maintains body water homeostasis. Vasopressin activates PKA, which phosphorylates AQP2, and this phosphorylation event is required to increase the water permeability and water reabsorption of the collecting duct cells. It has been established that the phosphorylation of AQP2 induces its apical membrane insertion, rendering the cell water-permeable. However, whether this phosphorylation regulates the water permeability of this channel still remains unclear. To clarify the role of AQP2 phosphorylation in water permeability, we expressed recombinant human AQP2 in Escherichia coli, purified it, and reconstituted it into proteoliposomes. AQP2 proteins not reconstituted into liposomes were removed by fractionating on density step gradients. AQP2-reconstituted liposomes were then extruded through polycarbonate filters to obtain unilamellar vesicles. PKA phosphorylation significantly increased the osmotic water permeability of AQP2-reconstituted liposomes. We then examined the roles of AQP2 phosphorylation at Ser-256 and Ser-261 in the regulation of water permeability using phosphorylation mutants reconstituted into proteoliposomes. The water permeability of the non-phosphorylation-mimicking mutant S256A-AQP2 and non-phosphorylated WT-AQP2 was similar, and that of the phosphorylation-mimicking mutant S256D-AQP2 and phosphorylated WT-AQP2 was similar. The water permeability of S261A-AQP2 and S261D-AQP2 was similar to that of non-phosphorylated WT-AQP2. This study shows that PKA phosphorylation of AQP2 at Ser-256 enhances its water permeability.

Verified
Journal Article
Open access
PDF file
YNYumi Noda
Yumi Noda
SSSei Sasaki
Sei Sasaki
Ensuring the proper amount of water inside the body is essential for survival. One of the key factors in the maintenance of body water balance is water reabsorption in the collecting ducts of the kidney, a process that is regulated by aquaporin-2 (AQP2). AQP2 is a channel that is exclusively selective for water molecules and impermeable to ions or other small molecules. Impairments of AQP2 result in various water balance disorders, including nephrogenic diabetes insipidus (NDI), which is a disease characterized by a massive loss of water through the kidney and consequent severe dehydration. Dysregulation of AQP2 is also a cause of water retention with hyponatremia in heart failure, hepatic cirrhosis, and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Antidiuretic hormone vasopressin is an upstream regulator of AQP2. Its binding to the vasopressin V2 receptor promotes AQP2 targeting to the apical membrane and thus enables water reabsorption. Tolvaptan, a vasopressin V2 receptor antagonist, is effective and widely used for water retention with hyponatremia. However, there are no studies showing improvement in hard outcomes or long-term prognosis. A possible reason is that vasopressin receptors have many downstream effects other than AQP2 function. It is expected that the development of drugs that directly target AQP2 may result in increased treatment specificity and effectiveness for water balance disorders. This review summarizes recent progress in studies of AQP2 and drug development challenges for water balance disorders.